Among all Lynch syndrome deleterious and suspected deleterious mutations detected, 17.2% (189/1,098) were LRs in MLH1, MSH2, MSH6, or EPCAM compared with 82.8% (909/1,098) sequencing mutations in MLH1, MSH2, and MSH6 (Table 1). The gene discussed is EPCAM; the disease is Lynch syndrome.